In furtherance to the intimation captioned ‘US FDA Inspection at Company’s API manufacturing facility located at Mandva’ dated 01st December, 2023, Alkem Laboratories has informed that US FDA has issued an Establishment Inspection Report (EIR) for the said manufacturing facility. The Inspection has been classified as Voluntary Action Indicated (VAI) and was closed accordingly.
The above information is a part of company’s filings submitted to BSE.